HYPERRABS/D (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the HYPERRAB drug offered from GRIFOLS USA, LLC. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
| NON-PROPRIETARY NAME: | RABIES IMMUNE GLOBULIN (HUMAN) |
| SUBSTANCE NAME: | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1996-08-14 |
| END MARKETING DATE: | 0000-00-00 |
HYPERRAB S/D PLASMA DERIVATIVE Details:
| Item Description | HYPERRAB S/D from GRIFOLS USA, LLC |
| LABELER NAME: | GRIFOLS USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150([iU]/mL) |
| START MARKETING DATE: | 1996-08-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13533-618_9cecb9f3-a123-4051-9dea-d2a39c74c4cf |
| PRODUCT NDC: | 13533-618 |
| APPLICATION NUMBER: | BLA101144 |
Other HUMAN RABIES VIRUS IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:
